Calidi Biotherapeutics (CLDI) Assets Average (2022 - 2025)
Calidi Biotherapeutics' quarterly Assets Average came in at $11.4 million in Q4 2025, up 9.82% year-on-year from $10.4 million in Q4 2024, and down 2.11% quarter-over-quarter from $11.7 million in Q3 2025.
Calidi Biotherapeutics has reported Assets Average for 4 years, with the latest figure at $11.4 million in Q4 2025.
- For the quarter ending Q4 2025, Assets Average rose 9.82% year-over-year to $11.4 million; the trailing twelve-month figure through Dec 2025 stood at $11.4 million (up 9.82% YoY), and the FY2025 full-year result was $11.5 million, down 4.8% from the prior year.
- Assets Average for Q4 2025 stood at $11.4 million, down from $11.7 million in the prior quarter.
- The five-year high for Assets Average was $231.5 million in Q1 2022, with the low at $6.5 million in Q3 2024.
- Average Assets Average over 4 years is $51.0 million, with a median of $14.5 million recorded in 2023.
- Year-over-year, Assets Average plunged 90.11% in 2023 and soared 78.64% in 2025.
- Tracing CLDI's Assets Average over 4 years: stood at $22.4 million in 2022, then plunged by 36.08% to $14.3 million in 2023, then declined by 27.15% to $10.4 million in 2024, then climbed by 9.82% to $11.4 million in 2025.
- The last three Assets Average figures came in at $11.4 million (Q4 2025), $11.7 million (Q3 2025), and $12.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 40.71 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | 26.03 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Calidi Biotherapeutics | - | - | - | 11.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.44 Mn |
| Sep 30, 2025 | 11.69 Mn |
| Jun 30, 2025 | 12.21 Mn |
| Mar 31, 2025 | 14.62 Mn |
| Dec 31, 2024 | 10.42 Mn |
| Sep 30, 2024 | 6.54 Mn |
| Jun 30, 2024 | 6.92 Mn |
| Mar 31, 2024 | 8.71 Mn |
| Dec 31, 2023 | 14.30 Mn |
| Sep 30, 2023 | 31.30 Mn |
| Jun 30, 2023 | 43.59 Mn |
| Mar 31, 2023 | 22.89 Mn |
| Dec 31, 2022 | 22.38 Mn |
| Sep 30, 2022 | 136.59 Mn |
| Jun 30, 2022 | 231.13 Mn |
| Mar 31, 2022 | 231.50 Mn |